{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:39:03Z","timestamp":1776130743339,"version":"3.50.1"},"reference-count":131,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["EXPL\/BIA-BQM\/1361\/2021"],"award-info":[{"award-number":["EXPL\/BIA-BQM\/1361\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["CENTRO-01-0246-FEDER-000010"],"award-info":[{"award-number":["CENTRO-01-0246-FEDER-000010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["UIDB\/00081\/2020"],"award-info":[{"award-number":["UIDB\/00081\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["LA\/P\/0056\/2020"],"award-info":[{"award-number":["LA\/P\/0056\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["UIDP\/04539\/2020"],"award-info":[{"award-number":["UIDP\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["LA\/P\/0058\/2020"],"award-info":[{"award-number":["LA\/P\/0058\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","award":["CENTRO-01-0145-FEDER-181226"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-181226"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a global pandemic affecting 25% of the world\u2019s population and is a serious health and economic concern worldwide. NAFLD is mainly the result of unhealthy dietary habits combined with sedentary lifestyle, although some genetic contributions to NAFLD have been documented. NAFLD is characterized by the excessive accumulation of triglycerides (TGs) in hepatocytes and encompasses a spectrum of chronic liver abnormalities, ranging from simple steatosis (NAFL) to steatohepatitis (NASH), significant liver fibrosis, cirrhosis, and hepatocellular carcinoma. Although the molecular mechanisms that cause the progression of steatosis to severe liver damage are not fully understood, metabolic-dysfunction-associated fatty liver disease is strong evidence that mitochondrial dysfunction plays a significant role in the development and progression of NAFLD. Mitochondria are highly dynamic organelles that undergo functional and structural adaptations to meet the metabolic requirements of the cell. Alterations in nutrient availability or cellular energy needs can modify mitochondria formation through biogenesis or the opposite processes of fission and fusion and fragmentation. In NAFL, simple steatosis can be seen as an adaptive response to storing lipotoxic free fatty acids (FFAs) as inert TGs due to chronic perturbation in lipid metabolism and lipotoxic insults. However, when liver hepatocytes\u2019 adaptive mechanisms are overburdened, lipotoxicity occurs, contributing to reactive oxygen species (ROS) formation, mitochondrial dysfunction, and endoplasmic reticulum (ER) stress. Impaired mitochondrial fatty acid oxidation, reduction in mitochondrial quality, and disrupted mitochondrial function are associated with a decrease in the energy levels and impaired redox balance and negatively affect mitochondria hepatocyte tolerance towards damaging hits. However, the sequence of events underlying mitochondrial failure from steatosis to hepatocarcinoma is still yet to be fully clarified. This review provides an overview of our understanding of mitochondrial adaptation in initial NAFLD stages and highlights how hepatic mitochondrial dysfunction and heterogeneity contribute to disease pathophysiology progression, from steatosis to hepatocellular carcinoma. Improving our understanding of different aspects of hepatocytes\u2019 mitochondrial physiology in the context of disease development and progression is crucial to improving diagnosis, management, and therapy of NAFLD\/NASH.<\/jats:p>","DOI":"10.3390\/biology12040595","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T04:54:24Z","timestamp":1681448064000},"page":"595","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria"],"prefix":"10.3390","volume":"12","author":[{"given":"Ricardo","family":"Amorim","sequence":"first","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, CIBB\u2014Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"CIQUP-IMS\/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal"}]},{"given":"Carina C.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, CIBB\u2014Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-2402","authenticated-orcid":false,"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[{"name":"CIQUP-IMS\/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal"}]},{"given":"Paulo J.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, CIBB\u2014Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-5698","authenticated-orcid":false,"given":"Jos\u00e9","family":"Teixeira","sequence":"additional","affiliation":[{"name":"CNC\u2014Center for Neuroscience and Cell Biology, CIBB\u2014Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: From obesity to metabolic syndrome and diabetes","volume":"12","author":"Valerio","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of non-alcoholic fatty liver disease: A population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between non-alcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in non-alcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in the United States and the Rest of the World","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep4.1599","article-title":"The Growing Burden of Disability Related to Non-alcoholic Fatty Liver Disease: Data from the Global Burden of Disease 2007\u20132017","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in non-alcoholic fatty liver vs non-alcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/oby.2010.248","article-title":"The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: Sex and race differences","volume":"19","author":"Camhi","year":"2011","journal-title":"Obesity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Non-alcoholic Fatty Liver Disease: An Emerging Driver of Hypertension","volume":"75","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Non-alcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"Guerrero","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1038\/s41598-018-27377-2","article-title":"Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: The NHANES III Linked Mortality Study","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101111","DOI":"10.1016\/j.molmet.2020.101111","article-title":"Genetic and epigenetic factors determining NAFLD risk","volume":"50","author":"Jonas","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep4.1822","article-title":"TM6SF2: A Novel Genetic Player in Non-alcoholic Fatty Liver and Cardiovascular Disease","volume":"6","author":"Luo","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bor\u00e9n, J., Adiels, M., Bj\u00f6rnson, E., Matikainen, N., S\u00f6derlund, S., R\u00e4m\u00f6, J., St\u00e5hlman, M., Ripatti, P., Ripatti, S., and Palotie, A. (JCI Insight, 2020). Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans, JCI Insight, Epub ahead of print.","DOI":"10.1172\/jci.insight.144079"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.24806","article-title":"Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents","volume":"55","author":"Santoro","year":"2012","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BJ20120163","article-title":"Effects of a glucokinase activator on hepatic intermediary metabolism: Study with 13C-isotopomer-based metabolomics","volume":"444","author":"Nissim","year":"2012","journal-title":"Biochem. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2017.02.014","article-title":"Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD","volume":"67","author":"Luukkonen","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Luukkonen, P.K., Tukiainen, T., Juuti, A., Sammalkorpi, H., Haridas, P.N., Niemel\u00e4, O., Arola, J., Orho-Melander, M., Hakkarainen, A., and Kovanen, P.T. (JCI Insight, 2020). Hydroxysteroid 17-\u03b2 dehydrogenase 13 variant increases phospholipids and protects against fibrosis in non-alcoholic fatty liver disease, JCI Insight, Epub ahead of print.","DOI":"10.1172\/jci.insight.132158"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease","volume":"378","author":"Cheng","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Helsley, R.N., Varadharajan, V., Brown, A.L., Gromovsky, A.D., Schugar, R.C., Ramachandiran, I., Fung, K., Kabbany, M.N., Banerjee, R., and Neumann, C.K. (eLife, 2019). Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease, eLife, Epub ahead of print.","DOI":"10.7554\/eLife.49882"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: From new variants to the clinic","volume":"72","author":"Valenti","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"Pirazzi","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of non-alcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jgh.12714","article-title":"Common variant in the glucokinase regulatory gene rs780094 and risk of non-alcoholic fatty liver disease: A meta-analysis","volume":"30","author":"Zain","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_30","first-page":"70","article-title":"The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes","volume":"51","author":"Andersen","year":"2008","journal-title":"Diabetologia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1194\/jlr.P089953","article-title":"Splice variant rs72613567 prevents worst histologic outcomes in patients with non-alcoholic fatty liver disease","volume":"60","author":"Pirola","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis","volume":"20","author":"Takahashi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Non-alcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and Mechanisms of Non-alcoholic Fatty Liver Disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, Pathogenesis, and Treatment of Non-alcoholic Steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Non-alcoholic fatty liver disease: Pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"770986","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and Non-Alcoholic Fatty Liver Disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Adolph, T.E., Grander, C., Grabherr, F., and Tilg, H. (2017). Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int. J. Mol. Sci., 148.","DOI":"10.3390\/ijms18081649"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e03263-19","DOI":"10.1128\/mBio.03263-19","article-title":"Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Non-alcoholic Fatty Liver Disease","volume":"11","author":"Fei","year":"2020","journal-title":"MBio"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"708959","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression","volume":"12","author":"Mattos","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj2310439","article-title":"Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob\/ob) mice","volume":"231","author":"Brady","year":"1985","journal-title":"Biochem. J."},{"key":"ref_50","first-page":"S627","article-title":"The effect of oleic and palmitic acid on induction of steatosis and cytotoxicity on rat hepatocytes in primary culture","volume":"64","author":"Mezera","year":"2015","journal-title":"Physiol. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Amorim, R., Sim\u00f5es, I.C.M., Veloso, C., Carvalho, A., Sim\u00f5es, R.F., Pereira, F.B., Thiel, T., Normann, A., Morais, C., and Jurado, A.S. (2021). Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells. Nutrients, 13.","DOI":"10.3390\/nu13051723"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cmet.2018.03.003","article-title":"Mitochondria Bound to Lipid Droplets Have Unique Bioenergetics, Composition, and Dynamics that Support Lipid Droplet Expansion","volume":"27","author":"Benador","year":"2018","journal-title":"Cell Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.27409","article-title":"Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"101134","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: Friend or foe?","volume":"50","author":"Shum","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1210\/me.2015-1069","article-title":"Liver Perilipin 5 Expression Worsens Hepatosteatosis but Not Insulin Resistance in High Fat-Fed Mice","volume":"29","author":"Trevino","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1074\/jbc.M805768200","article-title":"The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria","volume":"284","author":"Stone","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.30765","article-title":"Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis without Increasing Inflammation or Fibrosis in Mice","volume":"70","author":"Gluchowski","year":"2019","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.mehy.2005.09.009","article-title":"Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary p","volume":"66","author":"Tapia","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1146\/annurev.biochem.76.071905.090048","article-title":"The machines that divide and fuse mitochondria","volume":"76","author":"Hoppins","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.freeradbiomed.2019.07.017","article-title":"Mitohormesis and metabolic health: The interplay between ROS, cAMP and sirtuins","volume":"141","author":"Palmeira","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1074\/jbc.R111.271999","article-title":"Signal transduction by mitochondrial oxidants","volume":"287","author":"Finkel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1478-3231.2005.01126.x","article-title":"Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease","volume":"25","author":"Perlemuter","year":"2005","journal-title":"Liver Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","article-title":"NAD(+) in Aging: Molecular Mechanisms and Translational Implications","volume":"23","author":"Fang","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_64","first-page":"1609","article-title":"SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF-\u03baB pathway in mouse kupffer cells","volume":"18","author":"Niu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3803\/EnM.2019.34.1.39","article-title":"Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases","volume":"34","author":"Yi","year":"2019","journal-title":"Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.28245","article-title":"Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice","volume":"63","author":"Gariani","year":"2016","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"17238","DOI":"10.1038\/s41598-017-17574-w","article-title":"GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury","volume":"7","author":"Chung","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cmet.2007.02.009","article-title":"Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression","volume":"5","author":"Bonawitz","year":"2007","journal-title":"Cell Metab."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ferr\u00edn, G., Guerrero, M., Amado, V., Rodr\u00edguez-Per\u00e1lvarez, M., and De la Mata, M. (2020). Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041266"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.ircmb.2018.05.002","article-title":"Mitohormesis, an Antiaging Paradigm","volume":"340","author":"Mayoral","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/toxsci\/kfu184","article-title":"Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice","volume":"142","author":"Lee","year":"2014","journal-title":"Toxicol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1476-511X-12-165","article-title":"Nrf2 deletion causes \u2018benign\u2019 simple steatosis to develop into non-alcoholic steatohepatitis in mice fed a high-fat diet","volume":"12","author":"Wang","year":"2013","journal-title":"Lipids Health Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"102427","DOI":"10.1016\/j.isci.2021.102427","article-title":"Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling","volume":"24","author":"Wang","year":"2021","journal-title":"iScience"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/BJ20080868","article-title":"High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo","volume":"417","author":"Mantena","year":"2009","journal-title":"Biochem. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","article-title":"Fatty liver is associated with impaired activity of PPAR\u03b3-coactivator 1\u03b1 (PGC1\u03b1) and mitochondrial biogenesis in mice","volume":"91","author":"Pen","year":"2011","journal-title":"Lab. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1440-1746.2006.04640.x","article-title":"Role of mitochondria in non-alcoholic fatty liver disease","volume":"22","author":"Pessayre","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00535-012-0739-0","article-title":"Increased hepatic oxidative DNA damage in patients with non-alcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"48","author":"Tanaka","year":"2013","journal-title":"J. Gastroenterol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.metabol.2008.03.010","article-title":"Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity","volume":"57","author":"Takamura","year":"2008","journal-title":"Metabolism"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbalip.2015.03.003","article-title":"Peroxisomes compensate hepatic lipid overflow in mice with fatty liver","volume":"1851","author":"Knebel","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmet.2010.07.003","article-title":"Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity","volume":"12","author":"Li","year":"2010","journal-title":"Cell. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/ijbs.78525","article-title":"Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in non-alcoholic fatty liver disease","volume":"19","author":"Zhu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Non-alcoholic Steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/ars.2013.5486","article-title":"Reactive oxygen and nitrogen species in steatotic hepatocytes: A molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver","volume":"21","author":"Reiniers","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/sj.ijo.0802500","article-title":"Molecular mechanisms of inflammation in obesity-linked insulin resistance","volume":"27","author":"Marette","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1472-8206.2009.00765.x","article-title":"Effects of \u03b2-aminoisobutyric acid on leptin production and lipid homeostasis: Mechanisms and possible relevance for the prevention of obesity","volume":"24","author":"Begriche","year":"2010","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in non-alcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/ars.2010.3395","article-title":"Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice","volume":"15","author":"Eccleston","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4166\/kjg.2010.55.6.384","article-title":"Effects of carnitine on peripheral blood mitochondrial DNA copy number and liver function in non-alcoholic fatty liver disease","volume":"55","author":"Lim","year":"2010","journal-title":"Korean J. Gastroenterol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with non-alcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cmet.2015.07.027","article-title":"Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis","volume":"22","author":"Gray","year":"2015","journal-title":"Cell. Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.molmet.2017.09.002","article-title":"The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity","volume":"6","author":"Rauckhorst","year":"2017","journal-title":"Mol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Ma, X., McKeen, T., Zhang, J., and Ding, W.-X. (2020). Role and Mechanisms of Mitophagy in Liver Diseases. Cells, 9.","DOI":"10.3390\/cells9040837"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: A systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"101051","DOI":"10.1016\/j.molmet.2020.101051","article-title":"Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance","volume":"41","author":"Edmunds","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/MCB.00167-12","article-title":"BNip3 regulates mitochondrial function and lipid metabolism in the liver","volume":"32","author":"Glick","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/ars.2018.7544","article-title":"Peroxiredoxin 6 Confers Protection Against Non-alcoholic Fatty Liver Disease Through Maintaining Mitochondrial Function","volume":"31","author":"Lee","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Simoes, I.C.M., Karkucinska-Wieckowska, A., Janikiewicz, J., Szymanska, S., Pronicki, M., Dobrzyn, P., Dabrowski, M., Do-brzyn, A., Oliveira, P.J., and Zischka, H. (2020). Western Diet Causes Obesity-Induced Nonalcoholic Fatty Liver Disease Development by Differentially Compromising the Autophagic Response. Antioxidants, 9.","DOI":"10.3390\/antiox9100995"},{"key":"ref_100","unstructured":"Gnaiger, E., and Gnaiger, E. (2012). An Introduction to OXPHOS Analysis, OROBOROS MiPNet Publications."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Non-alcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.1000889","article-title":"Drug antigenicity, immunogenicity, and costimulatory signaling: Evidence for formation of a functional antigen through immune cell metabolism","volume":"185","author":"Elsheikh","year":"2010","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/hep.27216","article-title":"Hepatic DNA deposition drives drug-induced liver injury and inflammation in mice","volume":"61","author":"Marques","year":"2015","journal-title":"Hepatology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12272-019-01178-1","article-title":"Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"G193","DOI":"10.1152\/ajpgi.00426.2001","article-title":"Non-alcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis","volume":"282","author":"Pessayre","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1572-0241.2007.01709.x","article-title":"Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment","volume":"103","author":"Zein","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives non-alcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Santoro","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","article-title":"Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion","volume":"274","author":"Chavin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e2186","DOI":"10.1038\/cddis.2016.66","article-title":"Calpain 2-mediated autophagy defect increases susceptibility of fatty livers to ischemia-reperfusion injury","volume":"7","author":"Zhao","year":"2016","journal-title":"Cell. Death Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1038\/cddis.2014.162","article-title":"Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD","volume":"5","author":"Mayoral","year":"2014","journal-title":"Cell. Death Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"101120","DOI":"10.1016\/j.redox.2019.101120","article-title":"Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy","volume":"21","author":"Zhou","year":"2019","journal-title":"Redox Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1073\/pnas.1108220109","article-title":"Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis","volume":"109","author":"Sorianello","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"103996","DOI":"10.1016\/j.isci.2022.103996","article-title":"Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver","volume":"25","author":"Yamada","year":"2022","journal-title":"iScience"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jhep.2014.07.024","article-title":"Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent","volume":"61","author":"Gan","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis","volume":"4","author":"Caballero","year":"2006","journal-title":"Cell. Metab."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jhep.2012.05.024","article-title":"Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis","volume":"57","author":"Matias","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1007\/s00125-016-4084-3","article-title":"Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice","volume":"59","author":"Merry","year":"2016","journal-title":"Diabetologia"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2337\/db08-0913","article-title":"Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress","volume":"58","author":"Delibegovic","year":"2009","journal-title":"Diabetes"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2014.04.043","article-title":"Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man","volume":"158","author":"Jais","year":"2014","journal-title":"Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/hep.28666","article-title":"Hepatocyte mitochondrial DNA released in microparticles and toll-like receptor 9 activation: A link between lipotoxicity and inflammation during non-alcoholic steatohepatitis","volume":"64","author":"Inzaugarat","year":"2016","journal-title":"Hepatology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00535-009-0112-0","article-title":"Hepatocellular carcinoma arising from non-cirrhotic non-alcoholic steatohepatitis","volume":"44","author":"Kawada","year":"2009","journal-title":"J. Gastroenterol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"102057","DOI":"10.1016\/j.ceca.2019.102057","article-title":"Deranged hepatocyte intracellular Ca(2+) homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma","volume":"82","author":"Ali","year":"2019","journal-title":"Cell. Calcium"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3389\/fphar.2018.01428","article-title":"The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches","volume":"9","author":"Xu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1158\/0008-5472.CAN-17-2039","article-title":"FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3\u03b2-Nrf2 Signaling","volume":"77","author":"Teng","year":"2017","journal-title":"Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.29484","article-title":"Hepatic peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b2 drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice","volume":"67","author":"Piccinin","year":"2018","journal-title":"Hepatology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcancer.2017.06.007","article-title":"The mitochondrial dynamics in cancer and immune-surveillance","volume":"47","author":"Simula","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/liv.13660","article-title":"Mitochondrial fission promotes cell migration by Ca(2+) \/CaMKII\/ERK\/FAK pathway in hepatocellular carcinoma","volume":"38","author":"Sun","year":"2018","journal-title":"Liver Int."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41416-019-0658-4","article-title":"MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming","volume":"122","author":"Zhang","year":"2020","journal-title":"Br. J. Cancer"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/4\/595\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:43Z","timestamp":1760123743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/4\/595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":131,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["biology12040595"],"URL":"https:\/\/doi.org\/10.3390\/biology12040595","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}